Clinical Roundup Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer March 14, 2025Vol.51 No.10
Clinical Roundup Investigational drug found to more than double survival time for glioblastoma patients in phase I study March 14, 2025Vol.51 No.10
Clinical Roundup Scientists identify strategy to fight cancer caused by Epstein-Barr virus March 14, 2025Vol.51 No.10
Clinical Roundup Combination therapy may overcome drug resistance in lung cancer with common KRAS mutation March 14, 2025Vol.51 No.10
Clinical Roundup Self-driving microscope solves previous challenges in microscopy March 14, 2025Vol.51 No.10
Clinical Roundup Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic CRC March 14, 2025Vol.51 No.10
Drugs & Targets EC approves Opdivo + Yervoy as first-line treatment for HCC March 14, 2025Vol.51 No.10
Drugs & Targets China’s National Medical Products Administration grants Breakthrough Therapy designation to olverembatinib for Ph+ ALL March 14, 2025Vol.51 No.10
Drugs & Targets FDA grants Orphan Drug designation to rhenium obisbemeda for leptomeningeal metastases in lung cancer March 14, 2025Vol.51 No.10
